One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk

Autor: M. L. Marcovecchio, Angelika Mohn, Valentina Chiavaroli, M. Bagordo, E. Marisi, T. de Giorgis, Francesco Chiarelli
Přispěvatelé: Marcovecchio, Loredana [0000-0002-4415-316X], Apollo - University of Cambridge Repository
Rok vydání: 2019
Předmět:
Blood Glucose
Male
endocrine system diseases
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Type 2 diabetes
030204 cardiovascular system & hematology
Overweight
Adolescents
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
Insulin
Child
Children
Glucose tolerance test
medicine.diagnostic_test
Insulin secretion
Insulin sensitivity
Cardiovascular Diseases
Child
Preschool

Female
medicine.symptom
medicine.medical_specialty
Adolescent
030209 endocrinology & metabolism
03 medical and health sciences
Insulin resistance
Metabolic Diseases
Internal medicine
Cardio-metabolic risk
Glucose Intolerance
medicine
Humans
Obesity
Retrospective Studies
business.industry
Cholesterol
nutritional and metabolic diseases
Anthropometry
Glucose Tolerance Test
medicine.disease
chemistry
Diabetes Mellitus
Type 2

1-H plasma glucose
Insulin Resistance
business
Biomarkers
DOI: 10.17863/cam.25982
Popis: PURPOSE: Obese adults with normal glucose tolerance (NGT) but with 1-hour post-load plasma glucose (1hPG) ≥ 155 mg/dl are at higher risk of developing type 2 diabetes (T2D) and cardiometabolic complications. Little information is available for the pediatric population, where recently, a lower cutoff, 132.5 mg/dl, has been suggested as being more sensitive to identify subjects at risk of T2D. Our aim was to assess whether obese Caucasian youth with 1hPG ≥ 132.5 mg/dl have worse insulin sensitivity and secretion and a worse cardiometabolic profile compared to obese youth with 1hPG < 132.5 mg/dl. METHODS: Medical records of 244 (43% male; age: 11.1 ± 2.7years) overweight/obese children and adolescents, who had undergone an oral glucose tolerance test (OGTT), were retrieved. Anthropometric and biochemical data were collected from the hard copy archive. Indexes of insulin resistance (HOMA-IR), insulin sensitivity (WBISI), and insulin secretion (Insulinogenic Index, Disposition Index) were calculated. RESULTS: Of the 244 records analyzed, 215 fulfilled criteria for NGT and had complete biochemical data. Among NGT patients, 42 (19.5%) showed 1hPG ≥ 132.5 mg/dL (high-NGT), while the remaining had 1hPG < 132.5 mg/dL (low-NGT). The high-NGT group showed a higher male prevalence (59.5 vs 37%), lower Disposition Index (0.54 [0.39-0.71] vs 0.79 [0.47-1.43]), and WBISI (0.24 [0.18-0.35] vs 0.33 [0.23-0.50]) than the low-NGT group. High-NGT subjects also showed a trend towards lower HDL-cholesterol and higher triglycerides/HDL-cholesterol ratio (2.13 [1.49-3.41] vs 1.66 [1.24-2.49]). CONCLUSIONS: In overweight/obese NGT Caucasian youth a 1hPG ≥ 132.5 mg/dL was able to identify those with impaired insulin sensitivity and secretion and a trend towards a worse cardio-metabolic profile, a group likely at risk for future T2D.
Databáze: OpenAIRE